Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Approval

Mifepristone

17 GOP Senators Press FDA Over Generic Mifepristone Approval

Republican senators set an Oct. 30 deadline for an explanation of the Sept. 30 generic approval.

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

FDA Approves Second Generic Mifepristone as White House Cites Legal Obligation

US Abortions Exceed 1.1 Million in 2024 as Telehealth and Surge States Fill Gaps